| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.867 | 0.001 | 0.867 | Nicotinic receptor alpha4 subunit antagonist | 0.545 0.002 DBMET01823 | ||
| 0.84 | 0.002 | 0.84 | Neuronal nicotinic receptor antagonist | 0.273 0.005 DBMET01823 | ||
| 0.826 | 0.002 | 0.826 | Acetylcholine nicotinic antagonist | 0.277 0.008 DBMET01823 | ||
| 0.696 | 0.003 | 0.696 | Acetylcholine antagonist | 0.238 0.023 DBMET01823 | ||
| 0.694 | 0.003 | 0.694 | Cholinergic antagonist | 0.24 0.023 DBMET01823 | ||
| 0.275 | 0.004 | 0.275 | Nicotinic alpha4beta2 receptor antagonist | 0.181 0.005 DBMET01823 | ||
| 0.369 | 0.098 | 0.369 | Analgesic | |||
| 0.251 | 0.028 | 0.251 | Cholinergic | |||
| 0.219 | 0.065 | 0.219 | Death-associated protein kinase 3 inhibitor | 0.17 0.097 DBMET01823 | ||
| 0.158 | 0.005 | 0.158 | Maillard reaction inhibitor | |||
| 0.162 | 0.014 | 0.162 | Acetylcholine nicotinic agonist | 0.111 0.03 DBMET01823 | ||
| 0.318 | 0.189 | 0.318 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.24 | 0.117 | 0.24 | Ca(v)3.3 blocker | 0.217 0.158 DBMET01823 | ||
| 0.109 | 0.011 | 0.109 | Nicotinic neuronal receptor agonist | 0.077 0.023 DBMET01823 | ||
| 0.103 | 0.012 | 0.103 | Nicotinic receptor alpha7 subunit antagonist | 0.083 0.016 DBMET01823 | ||
| 0.123 | 0.036 | 0.123 | Acetylcholine agonist | |||
| 0.104 | 0.044 | 0.104 | Potassium channel activator | |||
| 0.063 | 0.004 | 0.063 | Nicotinic alpha4beta2 receptor agonist | 0.036 0.011 DBMET01823 | ||
| 0.208 | 0.148 | 0.208 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.064 | 0.007 | 0.064 | Alpha 1L adrenoreceptor agonist | 0.053 0.013 DBMET01823 | ||
| 0.131 | 0.075 | 0.131 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.082 | 0.025 | 0.082 | 5 Hydroxytryptamine 3 agonist | |||
| 0.083 | 0.031 | 0.083 | Acetylcholine M5 receptor agonist | |||
| 0.066 | 0.017 | 0.066 | Nicotinic receptor alpha3 subunit antagonist | 0.061 0.019 DBMET01823 | ||
| 0.036 | 0.004 | 0.036 | Nicotinic alpha4 receptor agonist | 0.019 0.008 DBMET01823 | ||
| 0.054 | 0.024 | 0.071 | Dopamine beta hydroxylase inhibitor | 0.071 0.007 DBMET01823 | DBMET01823 | |
| 0.038 | 0.012 | 0.038 | Nicotinic alpha3beta4 receptor agonist | 0.027 0.026 DBMET01823 | ||
| 0.059 | 0.033 | 0.059 | 5 Hydroxytryptamine 7 agonist | |||
| 0.053 | 0.028 | 0.053 | Sodium/calcium exchanger inhibitor | |||
| 0.043 | 0.02 | 0.05 | Nicotinic receptor beta4 subunit antagonist | 0.05 0.016 DBMET01823 | DBMET01823 | |
| 0.036 | 0.017 | 0.036 | Potassium channel small-conductance Ca-activated activator | |||
| 0.021 | 0.008 | 0.021 | Potassium channel (Inward rectifier) 11 blocker | 0.02 0.009 DBMET01823 | ||
| 0.124 | 0.114 | 0.124 | CDC-like kinase 2 inhibitor | |||
| 0.026 | 0.017 | 0.026 | Thymidine phosphorylase inhibitor | 0.026 0.018 DBMET01823 | ||
| 0.042 | 0.034 | 0.042 | Glutamate (mGluR4) antagonist | |||
| 0.021 | 0.016 | 0.021 | Alpha 2d adrenoreceptor agonist | |||
| 0.054 | 0.051 | 0.058 | Alpha 2 adrenoreceptor agonist | 0.058 0.045 DBMET01823 | DBMET01823 | |
| 0.18 | 0.176 | 0.259 | Tyrosine 3 hydroxylase inhibitor | 0.259 0.06 DBMET01823 | DBMET01823 | |
| 0.052 | 0.051 | 0.052 | Cyclin H inhibitor | |||
| 0.041 | 0.069 | 0.056 | Alpha 1b adrenoreceptor agonist | 0.056 0.024 DBMET01823 | DBMET01823 | |
| 0.044 | 0.121 | 0.074 | CYP2A6 inhibitor | 0.074 0.054 DBMET01823 | DBMET01823 | |
| 0.037 | 0.305 | 0.102 | Thioredoxin inhibitor | 0.102 0.046 DBMET01823 | DBMET01823 | |
| 0.014 | 0.391 | 0.096 | Nitric oxide donor | 0.096 0.01 DBMET01823 | DBMET01823 | |
| 0.018 | 0.767 | 0.26 | Transcription factor inhibitor | 0.26 0.18 DBMET01823 | DBMET01823 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |